PCR Biosystems was founded in 2012 by two PCR experts who believed scientists deserved better performance and value from their PCR products.
PCR Biosystems have developed a range of PCR reagents that maximise yield and sensitivity from the simplest to most challenging of reactions. On average, our products outperform every competitor in terms of yield, specificity, sensitivity and speed. So your reactions have the best chance of working the way you want, first time.
We are a UK-based company, with an international team and a global sales force (38 distributors and counting). Our focus is on PCR and nothing else. Because we don’t rely on shareholders or venture capitalists, it lets us invest a large proportion of our profits into R&D: helping us make new reagents – and improve on the ones we already have.
The service we provide really matters to us too. We want to make sure you’re getting the most from our products, so our R&D team spend part of their working week responding to enquiries. It means that people contacting us with technical queries don’t just get expert advice – they’re often talking to the scientist who helped develop the reagent in the first place. It might help explain why our customers say we’re one of their favourite PCR companies to purchase reagents from.